REGISTRY:
Computershare Investor Services, 117 Victoria Street, West End Qld 4101
Tel : +61 7 3237 2100 or 1300 552 270
Fax : +61 7 3229 9860
RegistryEmail
Address: Level 2 , Brisbane Portal , 1 Breakfast Creek Road , NEWSTEAD , QLD, AUSTRALIA, 4006
Tel: 07 3250 1200 Fax: 07 3250 1299
Date first listed: 22/09/2000 Date delisted: 08/01/2008
Company Secretary: David Smith
Sector: Pharmaceuticals, Biotechnology & Life Sciences Industry Group:
Activities: Development and commercialisation of prescription therapeutic products for cancer
| delisted following completion of the scheme of arrangement with Peplin, Inc. (ASX Code: PLI), and in accordance with listing rule 17.11 | 08/01/2008 |
| we understand the scheme of arrangement involved a restructure and the Company becoming a wholly-owned subsidiary of Peplin Inc - shareholders and Optionholders receiving new Peplin shares and options (in the form of CDIs, unless shareholders elected otherwise) in the ratio of one share or one option for every 20 held | 08/01/2008 |
| announces that the Schemes of Arrangement have been implemented | 22/10/2007 |
| shares suspended from quotation | 08/10/2007 |
| name changed from Peplin Biotech Limited | 14/10/2004 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Cherrell Hirst | Non Exec Chairman | |
| Michael Aldridge | Managing Director, CEO | |
| Michael Spooner | Non Exec Director | |
| Gary Pace | Non Exec Director | |
| Eugene Bauer | Non Exec Director |